This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Brodsky RA (2014) Paroxysmal nocturnal hemoglobinuria. Blood 124:2804–2811. https://doi.org/10.1182/blood-2014-02-522128
Loschi M, Porcher R, Barraco F, Terriou L, Mohty M, de Guibert S, Mahe B, Lemal R, Dumas PY, Etienne G, Jardin F, Royer B, Bordessoule D, Rohrlich PS, Fornecker LM, Salanoubat C, Maury S, Cahn JY, Vincent L, Sene T, Rigaudeau S, Nguyen S, Lepretre AC, Mary JY, Corront B, Socie G, Peffault de Latour R (2016) Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study. Am J Hematol 91:366–370. https://doi.org/10.1002/ajh.24278
Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253–1258. https://doi.org/10.1056/NEJM199511093331904
Schrezenmeier H, Röth A, Araten DJ, Kanakura Y, Larratt L, Shammo JM, Wilson A, Shayan G, Maciejewski JP (2020) Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. Ann Hematol. https://doi.org/10.1007/s00277-020-04052-z
Babushok DV, Stanley N, Xie HM, Huang H, Bagg A, Olson TS, Bessler M (2017) Clonal replacement underlies spontaneous remission in paroxysmal nocturnal haemoglobinuria. Br J Haematol 176:487–490. https://doi.org/10.1111/bjh.13963
Korkama E-S, Armstrong A-E, Jarva H, Meri S (2018) Spontaneous remission in paroxysmal nocturnal hemoglobinuria—return to health or transition into malignancy? Front Immunol 9. https://doi.org/10.3389/fimmu.2018.01749
Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D (2010) ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. Br J Haematol 151:365–375. https://doi.org/10.1111/j.1365-2141.2010.08381.x
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from the patients included in the study.
Conflict of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Friedrich, C., Gay, J., Alary, A. et al. Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome. Ann Hematol (2020). https://doi.org/10.1007/s00277-020-04134-y
- Paroxysmal nocturnal hemoglobinuria
- Myelodysplastic syndrome
- Clonal dynamics